9I果冻制作厂官网

客户发表文献

论文在线提交

至今,GenScript的服务及产物已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

开始时间
页码: 112/360 每页显示数量
Functional characterization of a novel aminoglycoside phosphotransferase, APH(9)-Ic, and its variant from
Authors: Weina Shi, Junwan Lu, Chunlin Feng, Mengdi Gao, Anqi Li, Shuang Liu, Lei Zhang, Xueya Zhang, Qiaoling Li, Hailong Lin, Xi Lin, Kewei Li, Hailin Zhang, Yunliang Hu, Guangli Wang, Qiyu Bao, Weiyan Jiang
Journal: Front Cell Infect Microbiol
PubMed ID: 36699730
Doi: 10.3389/fcimb.2022.1097561
Lactate oxidase/catalase-displaying nanoparticles efficiently consume lactate in the tumor microenvironment to effectively suppress tumor growth
Authors: Hyukjun Choi, Mirae Yeo, Yujin Kang, Hyo Jeong Kim, Seong Guk Park, Eunjung Jang, Sung Ho Park, Eunhee Kim, Sebyung Kang
Journal: J Nanobiotechnology
PubMed ID: 36597089
Doi: 10.1186/s12951-022-01762-6
Vimentin epigenetic deregulation in Bladder Cancer associates with acquisition of invasive and metastatic phenotype through epithelial-to-mesenchymal transition
Authors: Sara Monteiro-Reis, Vera Miranda-Gon?alves, Catarina Guimar?es-Teixeira, Cláudia Martins-Lima, Jo?o Lobo, Diana Montezuma, Paula C Dias, Helene Neyret-Kahn, Isabelle Bernard-Pierrot, Rui Henrique, Carmen Jerónimo
Journal: Int J Biol Sci
PubMed ID: 36594099
Doi: 10.7150/ijbs.77181
SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression
Authors: Laura Cioetto-Mazzabò, Francesca Boldrin, Claire Beauvineau, Martin Speth, Alberto Marina, Amine Namouchi, Greta Segafreddo, Mena Cimino, Sandrine Favre-Rochex, Seetha Balasingham, Beatriz Trastoy, Hélène Munier-Lehmann, Gareth Griffiths, Brigitte Gicquel, Marcelo E Guerin, Riccardo Manganelli, Noelia Alonso-Rodríguez
Journal: Nucleic Acids Res
PubMed ID: 36546765
Doi: 10.1093/nar/gkac1173
Design of a chimeric ACE-2/Fc-silent fusion protein with ultrahigh affinity and neutralizing capacity for SARS-CoV-2 variants
Authors: Neil M Bodie, Rina Hashimoto, David Connolly, Jennifer Chu, Kazuo Takayama, Bruce D Uhal
Journal: Antib Ther
PubMed ID: 36741194
Doi: 10.1093/abt/tbad001
Cry51Aa Proteins Are Active against and Show a Mechanism Similar to Pore Formation Model
Authors: Ei Thinzar Soe, Zaw Lin Naing, Caihong Zhang, Lin Lin Niu, Jinrong Tang, Siqi Yu, Zhongwei Ding, Gemei Liang
Journal: J Agric Food Chem
PubMed ID: 36710440
Doi: 10.1021/acs.jafc.2c07244
Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
Authors: Kye Won Choe, Yong Kwan Lim, Oh Joo Kweon, Mi-Kyung Lee, Jin-Won Chung, Hye Ryoun Kim
Journal: Ann Lab Med
PubMed ID: 36544343
Doi: 10.3343/alm.2023.43.3.299
Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries
Authors: Eirini D Tseligka, Stéphanie Conzelmann, Yves Cambet, Tifany Schaer, Francesco Negro, Sophie Clément
Journal: JHEP Rep
PubMed ID: 36704052
Doi: 10.1016/j.jhepr.2022.100652
The effector Vm1G-1794 protects the aggregated MdEF-Tu from autophagic degradation to promote infection in apple
Authors: Runmin Che, Changhai Liu, Qi Wang, Wenyan Tu, Ping Wang, Chao Li, Xiaoqing Gong, Ke Mao, Hao Feng, Lili Huang, Pengmin Li, Fengwang Ma
Journal: Autophagy
PubMed ID: 36449354
Doi: 10.1080/15548627.2022.2153573
Tissue replication and mucosal swab detection of Sosuga virus in Syrian hamsters in the absence of overt tissue pathology and clinical disease
Authors: Stephen R Welch, Jana M Ritter, Amy J Schuh, Sarah C Genzer, Teresa E Sorvillo, Jessica R Harmon, JoAnn D Coleman-McCray, Shilpi Jain, Punya Shrivastava-Ranjan, Josilene Nascimento Seixas, Lindsey B Estetter, Pamela S Fair, Jonathan S Towner, Joel M Montgomery, César G Albari?o, Christina F Spiropoulou, Jessica R Spengler
Journal: Antiviral Res
PubMed ID: 36521633
Doi: 10.1016/j.antiviral.2022.105490

喜欢新升级的网站吗?

讨厌

不喜欢

一般

喜欢

非常喜欢

*